- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06108336
Cerebellar Involvement in Cognitive Sequencing
March 15, 2024 updated by: Johns Hopkins University
Investigation of Cerebellar Involvement in Cognitive Sequencing
Although there is increasing recognition that the cerebellum is involved in cognition as well as motor function, the manner in which the cerebellum contributes to cognition is uncertain.
One theory that might account for both motor and cognitive contributions of the cerebellum is that the cerebellum is involved in sequencing of relevant events or stimuli.
Previous experiments have suggested that disruption of the cerebellum impairs the prediction of the next event in a sequence.
The present experiment will examine the impact of cerebellar stimulation on brain activation during the performance of both sequence-demanding and non-sequence-demanding tasks.
Study Overview
Status
Recruiting
Detailed Description
Although there is increasing recognition that the cerebellum, which contains half of the brain's neurons, is involved in cognition as well as motor function, the manner in which the cerebellum contributes to cognition is uncertain.
The uniform circuitry of the cerebellum and the extensive connectivity of the cerebellum with numerous neocortical regions has suggested to some researchers that there is a common computation that the cerebellum performs for both motor and cognitive functions.
The cerebellar sequencing hypothesis posits that the cerebellum acquires sequence information, makes sequence predictions, and detects sequence violations.
These functions, executed via a forward model, could underlie cerebellar involvement in both motor and cognitive behavior.
In motor control, such predictions can be used to guide limb trajectory without reliance on movement-generated sensory feedback.
In cognition, sequencing requirements are prominent in both verbal working memory (VWM) and language acquisition; eg, in VWM, keeping a phone number in mind requires encoding and rehearsing a sequence of digits.
In language, words consist of sequences of syllables, and the learning of syllable transition probabilities is an important component of recognizing legal words in a language.
Importantly, prominent cerebellar activation has been observed in many functional MRI (fMRI) VWM and language studies.
However, the brainstem/cerebellar neural correlates of sequencing in cognition, and the influence of cerebellar sequence predictions on neocortical targets, are poorly understood.
In this experiment, studying healthy individuals the investigators will Investigate the cerebellum as a source of sequence prediction and its influence on forebrain areas.
The cerebellum is hypothesized to provide its forward model sequence prediction to forebrain targets, but to date no study has attempted to visualize with concurrent TMS/fMRI the consequences of disrupting this cerebellar input on forebrain activation.
In the investigators previous work, the investigators show that transcranial magnetic stimulation (TMS) during the rehearsal of a sequence of letters results in errors in determining if a probe letter matches the next letter in the sequence, suggesting that TMS disrupted this predictive input.
In accordance with this finding, the investigators hypothesize that, using concurrent TMS/fMRI, TMS disruption during a sequencing task will produce greater changes in neocortical activation relative to an analogous control task that does not have the predictive component brought out by sequencing demands.
The investigators further hypothesize that different patterns of neocortical activations in response to cerebellar TMS will be observed depending on whether a probe letter matches the expected next letter in a sequence.
Study Type
Interventional
Enrollment (Estimated)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: John E Desmond, Ph.D.
- Phone Number: 410-502-3583
- Email: jdesmon2@jhmi.edu
Study Contact Backup
- Name: Rida Saeed, BS
- Phone Number: 410-502-2150
- Email: rsaeed5@jhu.edu
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21205
- Recruiting
- Johns Hopkins University School of Medicine
-
Contact:
- John E. Desmond, Ph.D.
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- 1) Age 18-50;
- 2) educational attainment of at least 8 years;
- 3) capable of giving informed consent;
- 4) fluent speaker of English by self-report;
- 5) right handed.
Exclusion Criteria:
- 1) illicit drug use within 30 days of MRI scanning;
- 2) neurological or systemic disorder which can cause dementia or cognitive dysfunction;
- 3) history of an Axis I psychiatric disorder including substance use disorder;
- 4) history of definite stroke;
- 5) focal lesion on MRI exam;
- 6) uncorrected visual deficits by self-report
- 7) contraindications for MRI scanning
- 8) use of anxiolytic, antidepressant, neuroleptic, or sedative medication
- 9) Additional exclusion criteria recommended by Wassermann for TMS neuromodulation, including: History of seizure or a family history of epilepsy, heart disease, intracardiac lines, increased intracranial pressure, history of head trauma, and history of respiratory disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Cerebellar Stimulation
TMS will be administered to the cerebellum on half the trials of a sequence-demanding task, and on half the trials of a non-sequence-demanding task.
Task order will be counterbalanced.
|
TMS is administered during the execution of sequence-demanding task.
Transcranial magnetic stimulation (TMS) is a safe and non-invasive technique for transiently modulating brain activity
Other Names:
TMS is not administered during the execution of sequence-demanding task.
TMS is administered during the execution of non-sequence-demanding task.
Transcranial magnetic stimulation (TMS) is a safe and non-invasive technique for transiently modulating brain activity
TMS is not administered during the execution of non-sequence-demanding task
|
Active Comparator: Occipital Stimulation
TMS will be administered to an occipital control region on half the trials of a sequence-demanding task, and on half the trials of a non-sequence-demanding task.
Task order will be counterbalanced.
|
TMS is administered during the execution of sequence-demanding task.
Transcranial magnetic stimulation (TMS) is a safe and non-invasive technique for transiently modulating brain activity
Other Names:
TMS is not administered during the execution of sequence-demanding task.
TMS is administered during the execution of non-sequence-demanding task.
Transcranial magnetic stimulation (TMS) is a safe and non-invasive technique for transiently modulating brain activity
TMS is not administered during the execution of non-sequence-demanding task
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
functional magnetic resonance imaging brain activation
Time Frame: during scan up to 1 hour
|
functional magnetic resonance imaging brain activation.
For the sequential task, a sequence of letters is presented and the subject is presented with number signs, one at a time, to guide rehearsal of the sequence.
At some point a probe letter is presented and the subject indicates by button press if the probe is the next letter in the sequence.
For the non-sequential task, subjects do not have a guided rehearsal, and the response to the probe indicates if the probe was one of the letters originally presented.
Brain activation in response to the probe will be measured with brain stimulation vs no brain stimulation for each task
|
during scan up to 1 hour
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
percent correct of behavioral responses
Time Frame: during scan up to 1 hour
|
percent correct of behavioral responses.
For the sequential task, a sequence of letters is presented and the subject is presented with # signs, one at a time, to guide rehearsal of the sequence.
At some point a probe letter is presented and the subject indicates by button press if the probe is the next letter in the sequence.
For the non-sequential task, subjects do not have a guided rehearsal, and the response to the probe indicates if the probe was one of the letters originally presented.
Behavioral accuracy consists of the percent of correct responses to the probe, with higher numbers indicating better performance
|
during scan up to 1 hour
|
behavioral reaction time (milliseconds)
Time Frame: during scan up to 1 hour
|
behavioral reaction time to respond to the probe.
Increases in reaction time indicate greater difficulty for the subject to respond
|
during scan up to 1 hour
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: John E Desmond, Ph.D., Johns Hopkins University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2024
Primary Completion (Estimated)
July 31, 2026
Study Completion (Estimated)
July 31, 2027
Study Registration Dates
First Submitted
October 25, 2023
First Submitted That Met QC Criteria
October 25, 2023
First Posted (Actual)
October 31, 2023
Study Record Updates
Last Update Posted (Actual)
March 18, 2024
Last Update Submitted That Met QC Criteria
March 15, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- IRB00328214
- R01MH128278 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Effects of Cerebellar Stimulation on Brain Activation
-
University of ManchesterSuspendedThe Effects of Cerebellar rTMS on the BrainUnited Kingdom
-
Rennes University HospitalCompletedEffects of Neurotoxicants on the BrainFrance
-
University of ManitobaTerminatedUnderstand the Effects of tACS on the BrainCanada
-
Recep Tayyip Erdogan UniversityCompletedEffect of Irrigation Activation on Periapical HealingTurkey
-
Loma Linda UniversityCompletedFocus: Effect of Muscle Activation on CMAP in Normal HumansUnited States
-
Hvidovre University HospitalCompletedEffects of Lipids on Gastric Emptying | Effects of Lipids on Satiety Hormones | Effects of Lipids on AppetiteDenmark
-
Instituto Valenciano de Infertilidad, IVI VALENCIACompletedEffect of Two Protocols of Ovarian Stimulation on Oocyte QualitySpain
-
BrainswayWithdrawnEffect of Deep Transcranial Magnetic Stimulation on Memory
-
Hadassah Medical OrganizationHebrew University of JerusalemUnknownEffects of Smoking on InfantIsrael
Clinical Trials on TMS during sequence-demanding task
-
University of South CarolinaCompleted
-
University of South CarolinaCompleted
-
Duke UniversityCompletedEmotion Regulation | Real Versus Sham Transcranial Magnetic Stimulation (TMS)United States
-
Ali RezaiWithdrawnAlzheimer DiseaseUnited States
-
University of PennsylvaniaCures Within ReachCompletedPost Traumatic Stress Disorder | Major Depressive DisorderUnited States
-
Poitiers University HospitalCompletedAlzheimer Disease | Magnetic Resonance Spectroscopy | Memory Complaint | Phosphorylated Metabolism ProfileFrance
-
National Institute of Neurological Disorders and...WithdrawnNormal Physiology
-
National Taiwan University HospitalCompleted
-
University Hospital, LilleCompletedBlood Pressure | Anesthesia | Hemodynamic, MonitoringFrance
-
University Hospital, Strasbourg, FranceCompletedAttention Deficit Disorder | Hyperactivity DisorderFrance